Ronga G, Fiorentino A, Fragasso G, Fringuelli F M, Todino V
Ital J Surg Sci. 1986;16(1):11-5.
In 233 patients with differentiated thyroid carcinoma previously treated by total thyroidectomy supplemented, when necessary, with a therapeutic dose of 131I, serum thyroglobulin determinations and whole body scans were simultaneously performed. 82 of the 233 showed local or distant metastases: they were detected by both tests only in 36 cases. In 43 patients thyroglobulin was positive but without pathological concentrations of 131I at whole body scan were observed. The remaining 3 cases were detected on the basis of the positive whole body scan only, without increase in the circulating thyroglobulin. These results suggest that caution should be taken when considering thyroglobulin determination as possible substitutive test of whole body scan in the follow-up of differentiated thyroid carcinoma. However, for optimal sensitivity and reliability the complementary role of the two tests is stressed.
在233例曾接受甲状腺全切术治疗的分化型甲状腺癌患者中,必要时辅以治疗剂量的131I,同时进行血清甲状腺球蛋白测定和全身扫描。233例患者中有82例出现局部或远处转移:仅在36例中两项检查均检测到转移。43例患者甲状腺球蛋白呈阳性,但全身扫描未观察到131I的病理性聚集。其余3例仅根据全身扫描阳性检出,循环甲状腺球蛋白未升高。这些结果表明,在分化型甲状腺癌随访中,将甲状腺球蛋白测定视为全身扫描的可能替代检查时应谨慎。然而,为获得最佳的敏感性和可靠性,强调了两项检查的互补作用。